Devonian Health Group Inc. fell 19.3% on Tuesday, November 3, 2026, on 200 shares. No headline about GSD came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Devonian Health Group Inc. (GSD:TSXV) closed at $6.75 on November 5, 2026, unchanged on the day. The stock trades 55.0% below its 52-week high of $15.00 and 3,452.6% above its 52-week low of $0.190. Over the past year, it lost 42.3%. Devonian Health Group Inc. is part of the Life Sciences sector (Pharmaceuticals).
In 250 trading sessions since November 6, 2025, GSD closed higher on 45 days (18%). Its best day was July 9, 2026 (+75.78%) and its worst was July 17, 2026 (-30.32%). The stock moved 10% or more in a single session 34 times. It opened at least 5% above the previous day's high 21 times.
Devonian Health Group Inc is a late stage botanical pharmaceutical company with novel therapeutic approaches targeting unmet medical needs. It develops prescription botanical drugs.
Find more stocks like GSD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.